Class IIOngoing

Metoclopramide Tablets recall

FDA recall D-0473-2025 · initiated May 23, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of foreign tablets/capsules.

Details

Product: Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
Recalling company: Teva Pharmaceuticals USA, Inc.
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: USA Nationwide
Initiated: May 23, 2025
FDA report date: Jul 2, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0473-2025 ↗

← All drug recalls